Oramed Pharmaceuticals
ORMP
#8952
Rank
โ‚น12.42 B
Marketcap
โ‚น311.92
Share price
-8.04%
Change (1 day)
69.60%
Change (1 year)

EPS for Oramed Pharmaceuticals (ORMP)

EPS in 2025 (TTM): โ‚น74.01

According to Oramed Pharmaceuticals's latest financial reports the company's current EPS (TTM) is โ‚น73.66. In 2024 the company made an earnings per share (EPS) of -โ‚น43.65 a decrease over its 2023 EPS that were of โ‚น12.73.

EPS history for Oramed Pharmaceuticals from 2005 to 2025

Annual EPS

Year EPS Change
2025 (TTM)โ‚น74.01-269.55%
2024-โ‚น43.65-442.86%
2023โ‚น12.73-114.89%
2022-โ‚น85.4820.51%
2021-โ‚น70.9339.29%
2020-โ‚น50.93-31.71%
2019-โ‚น74.57-4.65%
2018-โ‚น78.218.86%
2017-โ‚น71.84-9.2%
2016-โ‚น79.1229.85%
2015-โ‚น60.938.06%
2014-โ‚น56.385.08%
2013-โ‚น53.653.51%
2012-โ‚น51.83137.5%
2011-โ‚น21.83-60%
2010-โ‚น54.56-0%
2009-โ‚น54.56-16.67%
2008-โ‚น65.48-25%
2007-โ‚น87.30700%
2006-โ‚น10.91303.56%
2005-โ‚น2.70

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Novo Nordisk
NVO
โ‚น319.51 333.76%๐Ÿ‡ฉ๐Ÿ‡ฐ Denmark
Sanofi
SNY
โ‚น187.80 154.96%๐Ÿ‡ซ๐Ÿ‡ท France
Ultragenyx Pharmaceutical
RARE
-โ‚น540.17-833.33%๐Ÿ‡บ๐Ÿ‡ธ USA
Lexicon Pharmaceuticals
LXRX
-โ‚น17.28-123.46%๐Ÿ‡บ๐Ÿ‡ธ USA
Compugen
CGEN
-โ‚น27.28-137.04%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel